Artificial intelligence-enabled updating and application of guideline-based algorithms for symptom management in adults with cancer: a concordance evaluation of cancer-related fatigue, depression, and pain
Year: 2026
Type: article
Abstract: Introduction Cancer-related fatigue, depression, and pain are highly prevalent, often co-occur and impair physical function, social activities, and quality of life among adults with cancer. Despite the availability of evidence-based clinical guidelines that provide recommendations for assessment and management, these symptoms remain under-recognized and undertreated. Clinical decision support systems (CDSS) can operationalize guideline-based symptom management algorithms at the point of care. However, maintaining these systems as evidence and practice evolve is labor-intensive, limiting adoption and sustainability. To address this gap, we sought to evaluate an artificial intelligence (AI)-enabled approach to updating guideline-based algorithms and generating patient-specific recommendations for managing fatigue, depression, and pain among adults with cancer. Methods This study evaluated AI performance (Gemini 3.0 Pro) for two tasks: identifying and interpreting updates to cancer symptom management guidelines for fatigue, depression, and pain, and producing casespecific recommendations aligned with an existing rule-based CDSS. Guideline updates were assessed against expert-judged reference standards using an ordinal rubric for detection, completeness, accuracy, and safety. Vignette-based recommendations were compared using precision, recall, and F1-score at the level of discrete clinical recommendation elements. Results For guideline updating, AI performance met pre-specified acceptability thresholds for fatigue and pain, with high completeness and accuracy and no clinical safety risk. Performance for depression was variable, driven by omission of guideline-supported integrative therapies and non-specific pharmacotherapy guidance. In vignette analyses, AI-generated recommendations showed strong concordance with the rule-based CDSS (F1 0.86–0.96). Most mismatches between AI and the CDSS came from AI leaving something out, not from giving unsafe advice. Discussion This suggests AI currently works best as a support tool rather than making clinical decisions on its own. Broader clinical use will require further work to test a greater number of test vignettes and its performance in real-world, multi-site settings with diverse patient populations.
Source: Frontiers in Medicine
Authors: Mary E. Cooley(Conceptualization, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing), James Shalaby(Conceptualization, Data curation, Formal analysis, Methodology, Software, Validation, Writing – review & editing), Marilyn J. Hammer(Formal analysis, Investigation, Writing – review & editing), Rachel A. Pozzar(Formal analysis, Investigation, Writing – review & editing), Kristin Roper(Formal analysis, Investigation, Writing – review & editing), Janet L. Abrahm(Formal analysis, Investigation, Resources, Writing – review & editing), Evan M. Graboyes(Investigation, Writing – review & editing), David F. Lobach(Conceptualization, Methodology, Software, Supervision, Writing – review & editing)
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236164940
